What Are DLBCL Relapse Symptoms Like After Remission?
At a Glance
DLBCL relapse can cause new or enlarging painless lymph nodes, drenching night sweats, unexplained fever, weight loss, severe fatigue, or symptoms in the area where lymphoma returns. Contact your oncology team promptly; sudden breathing, chest, or neurological problems require emergency care.
In this answer
3 sections
It is completely normal to feel anxious when active treatment ends and routine surveillance scans may stop or become less frequent. You might wonder, If I’m not getting regular scans, how will I know if my lymphoma has come back? The reassurance is that many relapses are discovered safely through physical symptoms and regular clinical checkups, rather than through scheduled surveillance imaging [1][2]. Medical guidelines generally do not recommend routine PET/CT scans for surveillance after a patient has reached a complete remission, as routine scans have not been shown to improve survival and can sometimes cause unnecessary anxiety or procedures due to false positives from normal inflammation or infection [1][2][3].
Instead of relying solely on scans, your survivorship care becomes a shared process. You will continue to have regular clinical follow-up visits with your oncology team, and together you will monitor your body for specific physical signs [1].
Physical Signs to Watch For
When DLBCL returns, it often shows up in the lymph nodes or causes systemic body changes known as B symptoms [4]. You should contact your oncology team promptly if you experience any of the following unexplained changes:
- Painless swollen lymph nodes: New or enlarging lumps under your skin, most commonly in your neck, armpits, or groin [5].
- Drenching night sweats: Waking up completely soaked, to the point where you need to change your clothes or bed sheets [4].
- Unexplained significant weight loss: Losing more than 10% of your body weight over six months without trying [4].
- Lingering fevers: Temperatures (typically 100.4°F / 38°C or higher) that come and go or persist without any obvious sign of a normal infection [4].
- Severe fatigue: Progressive exhaustion that feels out of proportion to your daily activities [6].
Other Possible Symptoms
Because DLBCL can sometimes return in areas outside of the lymph nodes (extranodal sites), you should also pay attention to localized symptoms. Depending on where the lymphoma was originally located or where it might return, these can include:
- Persistent chest pain, a new cough, or shortness of breath [7][8].
- New neurological changes like vision issues (such as double vision), severe headaches, or unusual weakness [9][10].
- New skin lesions, such as unusual plaques or bumps [11].
- Persistent abdominal fullness, early satiety (feeling full quickly), or unexplained bowel changes [12].
🚨 When to Seek Emergency Care:
While many symptoms warrant a prompt call to your oncologist, some require immediate emergency medical attention. Call 911 or go to the nearest emergency room if you experience severe shortness of breath, sudden and severe chest pain, new one-sided weakness, confusion, fainting, or other sudden neurological changes [8][9].
What to Do If You Notice Symptoms
Finding a new lump or having a fever can be terrifying when you have a history of cancer. However, it is important to remember that everyday infections, viruses, and benign inflammation can also cause these exact same symptoms [13][3]. Furthermore, the absence of symptoms does not replace your routine clinical follow-up, as some relapses are found during scheduled clinical exams before you notice them.
If you notice these physical signs, do not wait for your next scheduled appointment—contact your care team promptly. Your doctor will likely start with a physical exam and blood work, such as checking your complete blood count and lactate dehydrogenase (LDH) levels [4]. It is important to know that LDH is a non-specific marker; it can rise for many non-cancer reasons, and a normal result does not rule out a relapse, nor does a high result confirm one [4].
If your symptoms are highly suspicious for a relapse, your doctor may order a PET/CT scan to investigate further [14][1]. If the scan shows something concerning, your team will usually recommend a biopsy (taking a small tissue sample), when safe and feasible, to confirm whether it is actually lymphoma before starting any new treatments [3]. Scans alone cannot definitively diagnose a relapse, as inflammation can easily mimic cancer on a PET scan [3].
By knowing what to look for and attending your scheduled clinical follow-ups, you remain an active, empowered partner in your survivorship care.
Common questions in this guide
What are the most common warning signs of DLBCL relapse?
Does everyone with DLBCL need routine PET/CT scans after remission?
Which symptoms after DLBCL treatment mean I should go to the emergency room?
Can blood tests or LDH tell me whether DLBCL has relapsed?
How is a possible DLBCL relapse confirmed?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is the specific fever threshold at which I should call you, and should I go to the emergency room if it happens after hours?
- 2.What follow-up schedule (clinical exams and blood tests) do you recommend for me now that I am in remission?
- 3.Who is my best point of contact if I experience new symptoms between scheduled appointments?
- 4.Are there any specific localized symptoms I should be uniquely aware of based on where my original lymphoma was located?
- 5.What specific symptoms should prompt an immediate trip to the emergency room versus a call to your office?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (14)
- 1
FDG-PET/CT in the management of lymphomas: current status and future directions.
El-Galaly TC, Villa D, Gormsen LC, et al.
Journal of internal medicine 2018; (284(4)):358-376 doi:10.1111/joim.12813.
PMID: 29989234 - 2
PET/CT in Non-Hodgkin Lymphoma: An Update.
Zanoni L, Bezzi D, Nanni C, et al.
Seminars in nuclear medicine 2023; (53(3)):320-351 doi:10.1053/j.semnuclmed.2022.11.001.
PMID: 36522191 - 3
Usual and unusual pitfalls of 18F-FDG-PET/CT in lymphoma after treatment: a pictorial review.
Dubreuil J, Salles G, Bozzetto J, et al.
Nuclear medicine communications 2017; (38(7)):563-576 doi:10.1097/MNM.0000000000000697.
PMID: 28570287 - 4
Novel model predicts prognosis for patients with diffuse large B-cell lymphoma in first relapse after initial R-CHOP therapy: a single-institution study in China.
Wang W, Yin J, Zhang W, et al.
The Journal of international medical research 2021; (49(4)):3000605211002971 doi:10.1177/03000605211002971.
PMID: 33845607 - 5
Prognostic differences of refractory/relapsed nodal and extranodal diffuse large B-cell lymphoma in the chimeric antigen receptor T cell therapy era.
Song Z, Xu L, Tang G, et al.
Clinica chimica acta; international journal of clinical chemistry 2022; (532()):72-78 doi:10.1016/j.cca.2022.05.018.
PMID: 35660013 - 6
Peripheral Blood Lymphocyte-to-Monocyte Ratio at Relapse Predicts Outcome for Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma in the Rituximab Era.
Katoh D, Ochi Y, Yabushita T, et al.
Clinical lymphoma, myeloma & leukemia 2017; (17(12)):e91-e97 doi:10.1016/j.clml.2017.08.096.
PMID: 28918104 - 7
Recurrent Diffuse Large B-Cell Lymphoma Presenting with Pancoast Syndrome: A Rare Cause of Radicular Neck Pain in the Emergency Department.
Correia MS, Clark RF
The Journal of emergency medicine 2018; (55(3)):399-401 doi:10.1016/j.jemermed.2018.06.015.
PMID: 30049430 - 8
Haemodynamic instability secondary to cardiac involvement by lymphoma.
Lal KS, Tariq RZ, Okwuosa T
BMJ case reports 2016; (2016()).
PMID: 27307428 - 9
A 62-Year-Old-Man With Severe Daytime Sleepiness After Primary Central Nervous System Lymphoma.
Srikajon J, Tripipitsiriwat A, Orr JE
Chest 2026; (169(2)):e55-e60 doi:10.1016/j.chest.2025.08.017.
PMID: 41672658 - 10
Successful Use of Intravitreal Bevacizumab and Methotrexate in a Case of Neovascularization of the Iris and Pseudohypopyon Secondary to Recurrent Diffuse Large B-Cell Lymphoma.
Ahmed H, James A, Enghelberg M
Cureus 2022; (14(2)):e22578 doi:10.7759/cureus.22578.
PMID: 35371675 - 11
A 53-Year-Old Male with Relapsed Diffuse Large B-Cell Lymphoma on Chemotherapy with a New Leg Lesion.
Shi CR, Robinson SN, LaChance A, et al.
Dermatopathology (Basel, Switzerland) 2017; (4(1-4)):31-35 doi:10.1159/000481307.
PMID: 29456999 - 12
Primary diffuse large B-cell lymphoma of the rectus abdominis muscle: a presumed primary case report and literature review.
Duan X, Yue X, Cao J, et al.
Frontiers in oncology 2026; (16()):1837952 doi:10.3389/fonc.2026.1837952.
PMID: 42311256 - 13
Benign thyroid nodule mimicking residual disease on positron emission tomography/computed tomography in a patient with concurrent thyroid and gastric diffuse large B-cell lymphoma: the value of ultrasound-guided biopsy.
Tatoğlu MT, Özsoy MS
Journal of ultrasound 2026; doi:10.1007/s40477-026-01122-2.
PMID: 41663627 - 14
[Diffuse large B-cell lymphoma relapsing with intravascular large B-cell lymphoma-like perivascular and intravascular lesions].
Ishikawa T, Fukumi T, Moriyama T, et al.
[Rinsho ketsueki] The Japanese journal of clinical hematology 2019; (60(10)):1455-1461 doi:10.11406/rinketsu.60.1455.
PMID: 31695007
This page is for informational purposes only and does not constitute medical advice about possible DLBCL relapse. Contact your oncology team about new symptoms, and seek emergency care for severe or sudden warning signs.
Get notified when new evidence is published on Diffuse large B-cell lymphoma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.